£795.00

The 2023-2028 World Outlook for Streptococcal Infection Rapid Tests

Subjects

Price data last checked 8 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 83 days · 83 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 83 days • 1 price levels

Days at Price

Price Analysis

Most common price: £795 (83 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 83 days

Description

This study covers the world outlook for streptococcal infection rapid tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of streptococcal infection rapid tests as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbott Laboratories, Becton Dickinson and Company, bioMerieux, Bio-Rad Laboratories, and Cellabs. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format: paperback
ASIN: B09ZD148DZ
Category: Books > Subjects
Domain: Amazon UK
Release Date: 10 May 2022
Listed Since: 13 May 2022

The 2023-2028 World Outlook for Streptococcal Infection Rapid Tests

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2016-2021 Outlook for Streptococcal Infection Rapid Tests in the United States

The 2013-2018 Outlook for Streptococcal Infection Rapid Tests in India

The 2023-2028 Outlook for Gram-Positive Bacterial Infections in the United States

The 2023-2028 World Outlook for Sterility Testing Kits and Reagents

The 2023-2028 Outlook for Gram-Positive Bacterial Infections in India

The 2023-2028 Outlook for Test Strips in India

The 2023-2028 Outlook for Bloodstream Infection Testing in the United States

The 2026-2031 World Outlook for Conventional Bloodstream Infection Testing

Group C and group G Streptococci: Their Role in acute pharyngitis

The 2023-2028 Outlook for Bloodstream Infection Testing in India

The 2025-2030 World Outlook for Polyester Stick Packaging

Streptococci and the Host: 418 (Advances in Experimental Medicine and Biology, 418)

The 2025-2030 World Outlook for Systemic Antibiotics

The 2016-2021 Outlook for Stethoscopes in Japan

The 2026-2031 World Outlook for Systemic Antibiotics

The 2023-2028 Outlook for Infection Surveillance Solutions Software in the United States

The 2021-2026 World Outlook for Sexually Transmitted Diseases (STD) Treatments and Diagnoses

The 2016-2021 Outlook for Systemic Broad- And Medium-Spectrum Antibiotic Cephalosporins in Japan

The 2021-2026 World Outlook for Smart Antimicrobials

Medical Bacteriology. Volume 8: Streptococci

The 2023-2028 Outlook for Infection Surveillance Solutions Software in India

The 2023-2028 Outlook for Music Streaming in India

The 2021-2026 World Outlook for Antibacterial and Antiseptic Pharmaceuticals

The 2016-2021 Outlook for Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals in the United States